Identification and functional characterization of glioma-specific promoters and their application in suicide gene therapy

Journal of Neuro-Oncology

Volumn 104, Issue 2, 2011, Pages 497-507

  Yawata, Toshio ^a   Maeda, Yusuke ^a   Okiku, Makiko ^a   Ishida, Eri ^a   Ikenaka, Kazuhiro ^b   Shimizu, Keiji ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE FOR PHYSIOLOGICAL SCIENCES   (Japan)

Author keywords

Brain tumor; Cancer testis antigen; SSX4; Suicide gene therapy; Tumor specific promoter

Indexed keywords

ANTINEOPLASTIC AGENT; GANCICLOVIR; MELANOMA ANTIGEN 3; RETROVIRUS VECTOR; SYNOVIAL SARCOMA X BREAKPOINT 4 PROTEIN; TELOMERASE REVERSE TRANSCRIPTASE; THYMIDINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CANCER GENE THERAPY; CATALYSIS; CELL IMMORTALIZATION; COMPUTER MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFICACY; FEMALE; FIBROBLAST; GENE; GENE ACTIVITY; GENE CONTROL; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSDUCTION; GLIOBLASTOMA; GLIOMA CELL; HERPES SIMPLEX VIRUS THYMIDINE KINASE GENE; HUMAN; HUMAN CELL; MAGE A3 GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SSX4 GENE; SUICIDE GENE THERAPY; VIRAL GENE DELIVERY SYSTEM; VIRUS GENE;

EID: 80052620521     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-010-0522-0     Document Type: Article

References (35)

1. DeAngelis LM, Gutin PH, Leibel SA, Posner JB (2002) Intracranial tumors: diagnosis and treatment. Martin Dunitz, London, pp 367-394
2. MS Mahaley Jr C Mettlin N Natarajan ER Laws Jr BB Peace 1989 National survey of patterns of care for brain-tumor patients J Neurosurg 71 826 836 2585073 10.3171/jns.1989.71.6.0826 (Pubitemid 20008561)
3. DF Deen A Chiarodo EA Grimm, et al. 1993 Brain tumor working group report on the 9th international conference on brain tumor research and therapy. Organ system program, National Cancer Institute J Neurooncol 16 243 272 7905510 1:STN:280:DyaK2c7jt1yktg%3D%3D 10.1007/BF01057041 (Pubitemid 23335753)
4. KW Culver Z Ram S Walbridge H Ishii EH Oldfield RM Blaese 1992 In vivo gene transfer with retroviral vector producer cells for treatment of experimental brain tumors Science 256 1550 1552 1317968 1:CAS:528: DyaK38XltVeksrs%3D 10.1126/science.1317968
5. E Vincent R Vogels G Van Someren, et al. 1996 Herpes simplex virus thymidine kinase gene therapy for rat malignant brain tumors Human Gene Ther 7 197 205 1:CAS:528:DyaK28Xhtlyls74%3D 10.1089/hum.1996.7.2-197 (Pubitemid 26044838)
6. H Okada K Miyamura T Itoh, et al. 1996 Gene therapy against an experimental glioma using adeno-associated virus vectors Gene Ther 3 957 964 8940635 1:CAS:528:DyaK28XmvFahtrs%3D (Pubitemid 26397469)
7. CM Kramm M Chase U Herrlinger, et al. 1997 Therapeutic efficiency and safety of a second-generation replication-conditional HSV1 vector for brain tumor gene therapy Hum Gene Ther 8 2057 2068 9414254 1:CAS:528: DyaK2sXnslSktb8%3D 10.1089/hum.1997.8.17-2057 (Pubitemid 28072576)
8. DM Nettelbeck V Jérôme R Müller 2000 Gene therapy: designer promoters for tumour targeting Trends Genet 16 174 181 10729833 1:CAS:528:DC%2BD3cXit1Sqsbk%3D 10.1016/S0168-9525(99)01950-2 (Pubitemid 30169153)
9. K Tamura M Tamura K Ikenaka, et al. 2001 Eradication of murine brain tumors by direct inoculation of concentrated high titer-recombinant retrovirus harboring the herpes simplex virus thymidine kinase gene Gene Ther 8 215 222 11313793 1:CAS:528:DC%2BD3MXht1Gmtb4%3D 10.1038/sj.gt.3301371 (Pubitemid 32186133)
10. AS Majumdar DE Hughes SP Lichtsteiner Z Wang JS Lebkowski AP Vasserot 2001 The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters Gene Ther 8 568 578 11319624 1:CAS:528: DC%2BD3MXis1emurc%3D 10.1038/sj.gt.3301421 (Pubitemid 32409532)
11. JS Song HP Kim WS Yoon, et al. 2003 Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line Biosci Biotechnol Biochem 67 2344 2350 14646192 1:CAS:528:DC%2BD3sXps1emurc%3D 10.1271/bbb.67.2344 (Pubitemid 39251635)
12. V Hakin-Smith DA Jellinek D Levy, et al. 2003 Alternative lengthening of telomeres and survival in patients with glioblastoma multiforme Lancet 361 836 838 12642053 1:CAS:528:DC%2BD3sXitVKmtLs%3D 10.1016/S0140-6736(03)12681-5 (Pubitemid 36331849)
13. HJ Yun YH Cho Y Moon, et al. 2008 Transcriptional targeting of gene expression in breast cancer by the promoters of protein regulator of cytokinesis 1 and ribonuclease reductase 2 Exp Mol Med 40 345 353 18587273 1:CAS:528:DC%2BD1cXotlyktrk%3D 10.3858/emm.2008.40.3.345 (Pubitemid 351930677)
14. OL Caballero YT Chen 2009 Cancer/testis (CT) antigens: potential targets for immunotherapy Cancer Sci 100 2014 2021 19719775 1:CAS:528:DC%2BD1MXhsVSktLnK 10.1111/j.1349-7006.2009.01303.x
15. T Kumanishi F Ikuta T Yamamoto 1973 Brain tumors induced by Rous sarcoma virus, Schmidt-Ruppin stain III. Morphology of brain tumors induced in adult mice J Natl Cancer Inst 51 95 109
16. T Yoshimatsu M Tamura S Kuriyama K Ikenaka 1998 Improvement of retroviral packaging cell lines by introducing the polyomavirus early region Hum Gene Ther 9 161 172 9472776 1:CAS:528:DyaK1cXosVygtg%3D%3D 10.1089/hum.1998.9.2-161 (Pubitemid 28066161)
17. MJ Scanlan AO Gure AA Jungbluth, et al. 2002 Cancer/testis antigens: an expanding family of targets for cancer immunotherapy Immunol Rev 188 22 32 12445278 1:CAS:528:DC%2BD38Xps1Oqsr4%3D 10.1034/j.1600-065X.2002.18803.x (Pubitemid 35398862)
18. V Volloch B Schweitzer S Rits 1994 Ligation-mediated amplification of RNA from murine erythroid cells reveals a novel class of beta globin mRNA with an extended 5′-untranslated region Nucl Acids Res 22 2507 2511 8041612 1:CAS:528:DyaK2cXlvFOgsL4%3D 10.1093/nar/22.13.2507
19. Y Suzuki K Yoshitomo-Nakagawa K Maruyama A Suyama S Sugano 1997 Construction and characterization of a full length-enriched and a 5′-end-enriched cDNA library Gene 200 149 156 9373149 1:CAS:528: DyaK2sXmsVKksr8%3D 10.1016/S0378-1119(97)00411-3 (Pubitemid 27460481)
20. M Emerman HM Temin 1984 Genes with promoters in retrovirus vectors can be independently suppressed by an epigenetic mechanism Cell 39 449 467 6096005 1:STN:280:DyaL2M%2FnsVCmtg%3D%3D 10.1016/0092-8674(84)90453-7
21. I Panagopoulos F Mertens M Isaksson, et al. 2001 Clinical impact of molecular and cytogenetic findings in synovial sarcoma Genes Chromosomes Cancer 31 362 372 11433527 1:CAS:528:DC%2BD3MXls1emtbg%3D 10.1002/gcc.1155 (Pubitemid 32622713)
22. D Brett S Whitehouse P Antonson J Shipley C Cooper G Goodwon 2007 The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies Hum Mol Genet 6 1559 1564 10.1093/hmg/6.9.1559
23. FI Lim M Soulez D Koczan HJ Thiesen JC Knight 1998 A KRAB-related domain and a novel transcription repression domain in proteins encoded by SSX genes that are disrupted in human sarcomas Oncogene 17 2013 2018 9788446 1:CAS:528:DyaK1cXnt1Glt7s%3D 10.1038/sj.onc.1202122 (Pubitemid 28488471)
24. G Cronwright K Le Blanc C Götherström P Darcy M Ehnman B Brodin 2005 Cancer/testis antigen expression in human mesenchymal stem cells: down-regulation of SSX impairs cell migration and matrix metalloproteinase 2 expression Cancer Res 65 2207 2215 15781633 1:CAS:528:DC%2BD2MXisFGgu7o%3D 10.1158/0008-5472.CAN-04-1882 (Pubitemid 40490129)
25. M Maio S Coral E Fratta M Altomonte L Sigalotti 2003 Epigenetic targets for immune intervention in human malignancies Oncogene 22 6484 6488 14528272 1:CAS:528:DC%2BD3sXnsl2rsL4%3D 10.1038/sj.onc.1206956 (Pubitemid 37372328)
26. T Yawata E Nakai KC Park, et al. 2010 Enhanced expression of cancer testis antigen genes in glioma stem cells Mol Carcinog 49 532 544 20082319 1:CAS:528:DC%2BC3cXmslSrsrg%3D 10.1002/mc.20614
27. AO Güre IJ Wei LJ Old YT Chen 2002 The SSX gene family: characterization of 9 complete genes Int J Cancer 101 448 453 12216073 10.1002/ijc.10634
28. A Natsume T Wakabayashi K Tsujimura, et al. 2008 The DNA demethylating agent 5-aza-2′-deoxycytidine activates NY-ESO-1 antigenicity in orthotopic human glioma Int J Cancer 122 2542 2553 18240144 1:CAS:528:DC%2BD1cXltlaiu7w%3D 10.1002/ijc.23407 (Pubitemid 351590488)
29. Y Kang JA Hong GA Chen DM Nguyen DS Schrump 2007 Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells Oncogene 26 4394 4403 17260018 1:CAS:528: DC%2BD2sXntVCjur8%3D 10.1038/sj.onc.1210218 (Pubitemid 47014459)
30. L Liu K Ishihara T Ichimura, et al. 2009 MCAF1/AM is involved in Sp1-mediated maintenance of cancer-associated telomerase activity J Biol Chem 284 5165 5174 19106100 1:CAS:528:DC%2BD1MXhvVSntrc%3D 10.1074/jbc.M807098200
31. JH Leupold I Asangani GD Maurer E Lengyel S Post H Allgayer 2007 Src induces urokinase receptor gene expression and invasion/intravasation via activator protein-1/p-c-Jun in colorectal cancer Mol Cancer Res 5 485 496 17510314 1:CAS:528:DC%2BD2sXmtVOisr0%3D 10.1158/1541-7786.MCR-06-0211 (Pubitemid 46908466)
32. M Assimakopoulou J Varakis 2001 AP-1 and heat shock protein 27 expression in human astrocytoma J Cancer Res Clin Oncol 127 727 732 11768612 1:CAS:528:DC%2BD3MXot1yksbc%3D (Pubitemid 33079372)
33. H Tsuiki M Tnani I Okamoto, et al. 2003 Constitutively active forms of c-Jun NH2-terminal kinase are expressed in primary glial tumors Cancer Res 63 250 255 12517805 1:CAS:528:DC%2BD3sXjvFKntQ%3D%3D (Pubitemid 36070447)
34. Z Ram KW Culver EM Oshiro, et al. 1997 Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells Nat Med 12 1354 1361 10.1038/nm1297-1354 (Pubitemid 28011035)
35. WR Beyer M Westphal W Ostertag D von Laer 2002 Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range J Virol 76 1488 1495 11773421 1:CAS:528:DC%2BD38XnvFCqug%3D%3D 10.1128/JVI.76.3.1488-1495.2002 (Pubitemid 34066448)